Plasma lipidomic profiling identifies a novel complex lipid signature associated with ischemic stroke in chronic kidney disease

Rationale and objective: Despite contribution of dyslipidemia to ischemic stroke, plasma lipidomic correlates of stroke in CKD is not studied. This study is aimed to identify plasma lipid alterations associated with stroke. Study design: Cross sectional. Setting and population: 214 participants of Clinical Phenotyping and Resource Biobank Core (CPROBE). Clinical data and plasma samples at the time of recruitment were obtained and used to generate lipidomic data by liquid chromatography/mass-spectrometry-based untargeted platform. Predictors: Various levels of free fatty acids, acylcarnitines and complex lipids. Outcome: Stroke. Analytic approach: includes compound by compound comparison of lipids using t-test adjusted by false discovery rate in patients with and without stroke, and application of logistic regression analysis to identify independent lipid predictors of stroke and to estimate the odds associated with their various levels. Results: Overall, we identified 330 compounds. Enrichment analysis revealed overrepresentation of differentially regulated phosphatidylcholines (PC)s and phosphatidylethanolamines (PE)s were overrepresented in stroke (P<0.001). Abundance of PC38:4, PE36:4, PC34:0, and palmitate were significantly higher, but those of plasmenyl-PE (pPE)38:2, and PE 32:2 was significantly lower in patients with stroke (p≤0.0014). After adjusting, each 1-SD increase in palmitate and PC38:4 was independently associated with 1.84 fold (95% CI: 1.06–3.20, p=0.031) and 1.84 fold (1.11–3.05, p=0.018) higher risk of stroke, respectively. We observed a significant trend toward higher abundance of PCs, PEs, pPEs, and sphingomyelins in stroke (p≤0.046). Limitations: Small sample size; unclear, if similar changes in the same or opposite direction preceded stroke, as the cross-sectional nature of the observation does not allow determining the effect of time course on lipid alterations. Conclusion: Differential regulation of palmitate, PCs, and PEs in patients with CKD and a history of stroke may represent a previously unrecognized risk factor and might be a target of risk stratification and modification.

[1]  G. Michailidis,et al.  Increased lipogenesis and impaired β-oxidation predict type 2 diabetic kidney disease progression in American Indians. , 2019, JCI insight.

[2]  M. Kassiou,et al.  Multi-modal imaging of long-term recovery post-stroke by positron emission tomography and matrix-assisted laser desorption/ionisation mass spectrometry. , 2018, Rapid communications in mass spectrometry : RCM.

[3]  G. Michailidis,et al.  Lipidomics and Biomarker Discovery in Kidney Disease. , 2018, Seminars in nephrology.

[4]  Subramaniam Pennathur,et al.  Impaired β-Oxidation and Altered Complex Lipid Fatty Acid Partitioning with Advancing CKD. , 2017, Journal of the American Society of Nephrology : JASN.

[5]  M. Kassiou,et al.  Multi-modal imaging of long term recovery post-stroke by PET and MALDI-MS , 2018 .

[6]  Jia-ying Zhao,et al.  Potential serum biomarkers and metabonomic profiling of serum in ischemic stroke patients using UPLC/Q-TOF MS/MS , 2017, PloS one.

[7]  C. Chung,et al.  Free fatty acid as a determinant of ischemic lesion volume in nonarterial-origin embolic stroke , 2017, Journal of the Neurological Sciences.

[8]  D. Vance,et al.  The critical role of phosphatidylcholine and phosphatidylethanolamine metabolism in health and disease. , 2017, Biochimica et biophysica acta. Biomembranes.

[9]  M. Setou,et al.  Lysophosphatidylcholine Acyltransferase-3 Expression Is Associated with Atherosclerosis Progression , 2017, Journal of Vascular Research.

[10]  M. Fornage,et al.  Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association , 2017, Circulation.

[11]  Li Yang,et al.  Lipidomic analysis of plasma in patients with lacunar infarction using normal-phase/reversed-phase two-dimensional liquid chromatography–quadrupole time-of-flight mass spectrometry , 2017, Analytical and Bioanalytical Chemistry.

[12]  Amy Guzik,et al.  Stroke Epidemiology and Risk Factor Management , 2017, Continuum.

[13]  Fengguo Xu,et al.  Discovery of Metabolite Biomarkers for Acute Ischemic Stroke Progression. , 2017, Journal of proteome research.

[14]  Jiang He,et al.  Lipidomic Signature of Progression of Chronic Kidney Disease in the Chronic Renal Insufficiency Cohort , 2016, Kidney international reports.

[15]  Jeong-Yoon Choi,et al.  Free fatty acid as an outcome predictor of atrial fibrillation–associated stroke , 2016, Annals of neurology.

[16]  Min Liu,et al.  Potential of serum metabolites for diagnosing post-stroke cognitive impairment. , 2015, Molecular bioSystems.

[17]  Jing Liu,et al.  A metabonomic investigation on the biochemical perturbation in post-stroke patients with depressive disorder (PSD) , 2015, Metabolic Brain Disease.

[18]  Min-Jeong Shin,et al.  Plasma phospholipid arachidonic acid and lignoceric acid are associated with the risk of cardioembolic stroke. , 2015, Nutrition research.

[19]  M. Uyanık,et al.  A Biochemical View: Plasma Free Fatty Acids and Risk of Stroke in the Cardiovascular Health Study , 2015, International journal of stroke : official journal of the International Stroke Society.

[20]  D. Mozaffarian,et al.  Plasma Free Fatty Acids and Risk of Stroke in the Cardiovascular Health Study , 2014, International journal of stroke : official journal of the International Stroke Society.

[21]  Jeong-Yoon Choi,et al.  High free fatty acid level is associated with recurrent stroke in cardioembolic stroke patients , 2014, Neurology.

[22]  W. Rosamond,et al.  Serum Fatty Acids and Incidence of Ischemic Stroke Among Postmenopausal Women , 2013, Stroke.

[23]  Mary G. George,et al.  An Updated Definition of Stroke for the 21st Century: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association , 2013, Stroke.

[24]  J. Kastelein,et al.  Patients with low HDL-cholesterol caused by mutations in LCAT have increased arterial stiffness. , 2012, Atherosclerosis.

[25]  Chang Soon Choi,et al.  Global changes in phospholipids identified by MALDI MS in rats with focal cerebral ischemia[S] , 2012, Journal of Lipid Research.

[26]  S. Hansen,et al.  Visualization by mass spectrometry of 2‐dimensional changes in rat brain lipids, including N‐acylphosphatidylethanolamines, during neonatal brain ischemia , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[27]  Y. Kim,et al.  Elevated Free Fatty Acid is Associated with Cardioembolic Stroke Subtype , 2011, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[28]  A. Shevchenko,et al.  Human Lysophosphatidylcholine Acyltransferases 1 and 2 Are Located in Lipid Droplets Where They Catalyze the Formation of Phosphatidylcholine* , 2011, The Journal of Biological Chemistry.

[29]  A. Feher,et al.  Statintherapy in the primary and the secondary prevention of ischaemic cerebrovascular diseases. , 2011, International journal of cardiology.

[30]  Shen-Chih Chang,et al.  Low glomerular filtration rate and risk of stroke: meta-analysis , 2010, BMJ : British Medical Journal.

[31]  Cheng Bin Liu,et al.  Direct profiling of phospholipids and lysophospholipids in rat brain sections after ischemic stroke. , 2010, Rapid communications in mass spectrometry : RCM.

[32]  S. Yusuf,et al.  Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study , 2010, The Lancet.

[33]  P. Amarenco,et al.  Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention , 2009, The Lancet Neurology.

[34]  C. Choi,et al.  Estimating the probability of stroke in Korean hypertensive patients visiting tertiary hospitals using a risk profile from the framingham study , 2009, BMC neurology.

[35]  W. Sluiter,et al.  Plasma lecithin: cholesterol acyltransferase activity is elevated in metabolic syndrome and is an independent marker of increased carotid artery intima media thickness. , 2008, The Journal of clinical endocrinology and metabolism.

[36]  David C Hoaglin,et al.  Prediction of First Events of Coronary Heart Disease and Stroke With Consideration of Adiposity , 2008, Circulation.

[37]  R. D. de Haan,et al.  Statin Treatment and the Occurrence of Hemorrhagic Stroke in Patients With a History of Cerebrovascular Disease , 2008, Stroke.

[38]  C. Saha,et al.  Oral fish oil supplementation raises blood omega-3 levels and lowers C-reactive protein in haemodialysis patients--a pilot study. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[39]  Essam Elsayed,et al.  Cardiovascular outcomes and all-cause mortality: exploring the interaction between CKD and cardiovascular disease. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[40]  S. Perkins,et al.  Fish consumption and omega-3 fatty acid status and determinants in long-term hemodialysis. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[41]  Masahiko Watanabe,et al.  Diacylglycerol kinase ζ is involved in the process of cerebral infarction , 2006 .

[42]  Masahiko Watanabe,et al.  Diacylglycerol kinase zeta is involved in the process of cerebral infarction. , 2006, The European journal of neuroscience.

[43]  A. Zwinderman,et al.  Compromised LCAT Function Is Associated With Increased Atherosclerosis , 2005, Circulation.

[44]  E. Evans,et al.  Effect of chain length and unsaturation on elasticity of lipid bilayers. , 2000, Biophysical journal.

[45]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[46]  S. Yamawaki,et al.  Brain Ischemia Decreases Phosphatidylcholine‐Phospholipase D but Not Phosphatidylinositol‐Phospholipase C in Rats , 1994, Stroke.

[47]  R B D'Agostino,et al.  Probability of stroke: a risk profile from the Framingham Study. , 1991, Stroke.

[48]  M. Dechavanne,et al.  Platelet phospholipid in stroke. , 1978, Clinica chimica acta; international journal of clinical chemistry.

[49]  E. Horning,et al.  Analysis of long-chain acids or human plasma phosphatidylcholines (lecithins) and cholesteryl esters by glass open tubular capillary column gas chromatography for stroke patients and for normal subjects. , 1975, Journal of chromatography.

[50]  F. Yatsu,et al.  Brain Lipid Changes Following Hypoxia , 1971, Stroke.

[51]  W. J. Dyer,et al.  A rapid method of total lipid extraction and purification. , 1959, Canadian journal of biochemistry and physiology.